264 related articles for article (PubMed ID: 19120904)
1. Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease.
Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S234-6. PubMed ID: 19120904
[TBL] [Abstract][Full Text] [Related]
2. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
[TBL] [Abstract][Full Text] [Related]
3. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
[TBL] [Abstract][Full Text] [Related]
4. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects.
Stoltz RR; Harris SI; Kuss ME; LeComte D; Talwalker S; Dhadda S; Hubbard RC
Am J Gastroenterol; 2002 Jan; 97(1):65-71. PubMed ID: 11808971
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
Goldstein JL; Cryer B; Amer F; Hunt B
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
[TBL] [Abstract][Full Text] [Related]
7. Is Helicobacter pylori infection a risk or protective factor for mucosal lesions development in patients chronically treated with acetylsalicylic acid?
Kordecki H; Kurowski M; Kosik R; Pilecka D
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():85-91. PubMed ID: 9440059
[TBL] [Abstract][Full Text] [Related]
8. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers.
Lanza FL; Evans DG; Graham DY
Am J Gastroenterol; 1991 Jun; 86(6):735-7. PubMed ID: 2038996
[TBL] [Abstract][Full Text] [Related]
9. Clinical symptoms, endoscopic findings and histologic features of gastroduodenal non-steroidal anti-inflammatory drugs lesions.
Aabakken L
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S19-22. PubMed ID: 10379465
[TBL] [Abstract][Full Text] [Related]
10. Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction.
Bar Dayan Y; Amital H; Levy Y; Shoenfeld Y
Isr J Med Sci; 1996 May; 32(5):288-91. PubMed ID: 8641865
[TBL] [Abstract][Full Text] [Related]
11. Thirty-day mortality after peptic ulcer bleeding in hospitalized patients receiving low-dose aspirin at time of admission.
Mose H; Larsen M; Riis A; Johnsen SP; Thomsen RW; Sørensen HT
Am J Geriatr Pharmacother; 2006 Sep; 4(3):244-50. PubMed ID: 17062325
[TBL] [Abstract][Full Text] [Related]
12. Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs.
Takada M; Fukumoto K; Shibakawa M
J Clin Pharm Ther; 2004 Apr; 29(2):183-7. PubMed ID: 15068408
[TBL] [Abstract][Full Text] [Related]
13. Effects of alendronate on gastric and duodenal mucosa.
Lanza F; Rack MF; Simon TJ; Lombardi A; Reyes R; Suryawanshi S
Am J Gastroenterol; 1998 May; 93(5):753-7. PubMed ID: 9625122
[TBL] [Abstract][Full Text] [Related]
14. [Gastrointestinal hemorrhages as complications of gastropathies associated with intake of nonsteroidal anti-inflammatory drugs].
Shostak NA; Riabkova AA; Savel'ev VS; Maliarova LP
Ter Arkh; 2003; 75(5):70-3. PubMed ID: 12847903
[TBL] [Abstract][Full Text] [Related]
15. [Changes in stomach and duodenal mucosa caused by acetylsalicylic acid therapy].
Prochazka E; Pötzi R; Ehringer H; Gangl A
Acta Med Austriaca; 1988; 15(3):80-2. PubMed ID: 3146859
[TBL] [Abstract][Full Text] [Related]
16. [Upper gastrointestinal bleeding in patients treated by low-dose aspirin].
Capet C; Czernichow P; Dupas JL; Goria O; Gouérou H; Hochain P; Amouretti M; Herman H; Colin R
Gastroenterol Clin Biol; 2001 Mar; 25(3):233-8. PubMed ID: 11395668
[TBL] [Abstract][Full Text] [Related]
17. Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: a prospective, endoscopic study.
Chowdhury A; Ganguly G; Chowdhury D; Santra A; Gupta JD; Roy T
Indian J Gastroenterol; 2001; 20(6):227-9. PubMed ID: 11817775
[TBL] [Abstract][Full Text] [Related]
18. [Recurrence of gastropathies caused by intake of nonsteroidal anti-inflammatory drugs].
Karameev AE
Ter Arkh; 2003; 75(5):74-8. PubMed ID: 12847904
[TBL] [Abstract][Full Text] [Related]
19. [Endoscopic changes in the stomach and duodenal mucosa caused by minidose acetylsalicylic acid therapy and their prevention].
Novotný I; Díte P; Kunovská M; Münzová H
Vnitr Lek; 2007 Oct; 53(10):1053-6. PubMed ID: 18072429
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of gastric mucosal erosions in association with other upper gastrointestinal diseases, especially peptic ulcer disease, as revealed by elective gastroscopy.
Karvonen AL
Scand J Gastroenterol; 1982 Nov; 17(8):977-84. PubMed ID: 7167740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
